NASDAQ:ACTU | Income Statement | ACTUATE THERAPEUTICS, INC.

Complete source-backed income-statement history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$2.07M$4.91M-$4.91M$39,953.00-$4.87M-$0.20-$0.2023,871,85023,871,850
2026-03-31$2.57M$5.71M-$5.71M$80,207.00-$5.63M-$0.24-$0.2423,537,13423,537,134
2025-12-31$2.13M$4.69M-$4.69M$134,520.00-$4.55M-$0.18-$0.18835,111835,111
2025-09-30$2.18M$5.47M-$5.47M$64,908.00-$5.41M-$0.25-$0.2521,394,96521,394,965
2025-06-30$2.76M$5.97M-$5.97M$19,472.00-$5.95M-$0.30-$0.3019,646,47519,646,475
2025-03-31$3.22M$6.37M-$6.37M$48,560.00-$6.32M-$0.32-$0.3219,497,73119,497,731
2024-12-31$3.69M$6.56M-$6.56M$113,039.00-$6.45M$1.22$1.223,725,5423,725,542
2024-09-30$3.76M$5.39M-$5.39M-$578,058.00-$5.97M-$0.55-$0.5510,772,64010,772,640
2024-06-30$4.37M$5.44M-$5.44M-$1.14M-$6.57M-$4.20-$4.201,565,7771,565,777
2024-03-31$6.86M$7.77M-$7.77M-$522,805.00-$8.3M-$5.40-$5.401,535,1671,535,167
2023-12-31$6.65M$7.62M-$7.62M$3,027.00-$7.61M-$5.11-$5.1122,81322,813
2023-09-30$5.76M$6.48M-$6.48M$137,748.00-$6.34M-$4.31-$4.311,472,1821,472,182
2023-06-30$4.78M$5.58M-$5.58M$60,133.00-$5.52M-$3.88-$3.881,422,1641,422,164
2023-03-31-$5.27M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$10.29M$22.5M-$22.5M$267,460.00$800.00-$22.23M-$1.06-$1.0621,021,81721,021,817
2024-12-31$18.68M$25.16M-$25.16M-$2.12M$800.00-$27.29M-$3.26-$3.268,372,7418,372,741
2023-12-31$21.71M$24.97M-$24.97M$229,209.00$0.00-$24.74M-$17.24-$17.241,434,9641,434,964